Canaccord raised the firm’s price target on Heartflow (HTFL) to $39 from $35 and keeps a Buy rating on the shares. The firm updated its model following the release of its 10-Q and itsnew target reflects multiple expansion of the Elite Med-Tech comp group.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HTFL:
- HeartFlow, Inc.: Balancing Impressive Growth with Strategic Challenges – A Hold Recommendation
- HeartFlow Releases Investor Presentation at Healthcare Conference
- Elf Beauty downgraded, Zscaler upgraded: Wall Street’s top analyst calls
- Heartflow initiated with an Equal Weight at Morgan Stanley
- Heartflow initiated with a Buy at Canaccord